Monday - Friday, 6:00 - 7:00 PM ET

In this article

CNBC’s Jim Cramer on Monday told investors why he’s optimistic about CVS

, even as the healthcare sector as a whole has lagged this year.

″[It’s] fixing its most problematic business, managed care, and seeing real strength in other parts of the business, especially the pharmacy side, where it is the last man standing,” he said. “Plus, given the cheapness of the stock, generosity of the dividend yield — here’s what I’m saying: buy CVS.”